• 1. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 2. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 3. Enantiomeric two-fold interpenetrated 3D zinc(ii) coordination networks as a catalytic platform: significant difference between water within the cage and trace water in transesterification?
  Eunkyung Choi,Minjoo Ryu,Haeri Lee,Ok-Sang Jung Dalton Trans., 2017,46, 4595-4601
• 4. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 5. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739

Introduction to Rac-(2R,5R)-Pyrrolidine-2,5-Dicarboxylic Acid (CAS No. 49653-02-3)

Rac-(2R,5R)-pyrrolidine-2,5-dicarboxylic acid, identified by its CAS number 49653-02-3, is a significant compound in the field of pharmaceutical chemistry and biochemistry. This bicyclic amino dicarboxylic acid has garnered considerable attention due to its unique structural properties and potential applications in drug development and molecular research.

The compound belongs to the pyrrolidine family, which is characterized by a six-membered ring containing one nitrogen atom. The presence of two carboxylic acid groups at the 2 and 5 positions of the pyrrolidine ring imparts specific reactivity and functionality, making it a valuable building block for synthesizing more complex molecules. The stereochemistry of this compound, specifically the (2R,5R) configuration, plays a crucial role in determining its biological activity and interactions with biological targets.

In recent years, there has been growing interest in pyrrolidine derivatives due to their diverse pharmacological properties. Rac-(2R,5R)-pyrrolidine-2,5-dicarboxylic acid has been explored in various contexts, including its role as a precursor in the synthesis of peptidomimetics and other bioactive molecules. Its structural framework allows for modifications that can enhance binding affinity and selectivity towards specific biological targets.

One of the most compelling aspects of this compound is its potential application in the development of novel therapeutic agents. Researchers have leveraged its scaffold to design molecules with therapeutic potential in areas such as oncology, inflammation, and neurodegenerative diseases. The carboxylic acid groups provide multiple sites for chemical modification, enabling the creation of derivatives with tailored properties.

The synthesis of Rac-(2R,5R)-pyrrolidine-2,5-dicarboxylic acid involves multi-step organic reactions that require precise control over reaction conditions and stereochemistry. Advanced synthetic techniques, including asymmetric catalysis and chiral resolution methods, are often employed to achieve the desired stereochemical purity. These synthetic strategies not only highlight the compound's complexity but also showcase the advancements in synthetic chemistry that facilitate such intricate transformations.

Recent studies have demonstrated the utility of this compound in medicinal chemistry. For instance, it has been used as a key intermediate in the synthesis of inhibitors targeting enzymes involved in cancer progression. The pyrrolidine core is particularly well-suited for mimicking peptide sequences, allowing for the development of molecules that can modulate protein-protein interactions critical for disease pathways.

The biological activity of Rac-(2R,5R)-pyrrolidine-2,5-dicarboxylic acid has been investigated through both computational modeling and experimental assays. Computational studies have provided insights into its binding modes with potential target proteins, while experimental work has validated these predictions by assessing inhibitory effects on relevant enzymes and receptors. These combined approaches have underscored the compound's potential as a lead molecule for drug discovery.

In addition to its role in drug development, this compound has found applications in fundamental research. Its unique structure makes it a valuable tool for studying enzyme mechanisms and protein-ligand interactions. By serving as a scaffold for various modifications, researchers can probe different aspects of molecular recognition and design more effective ligands.

The future prospects for Rac-(2R,5R)-pyrrolidine-2,5-dicarboxylic acid are promising, with ongoing research exploring new synthetic routes and applications. As our understanding of biological systems continues to evolve, this compound is likely to play an increasingly important role in addressing complex diseases through innovative therapeutic strategies.

In conclusion, Rac-(2R,5R)-pyrrolidine-2,5-dicarboxylic acid (CAS No. 49653-02-3) is a versatile and significant compound with broad applications in pharmaceutical chemistry and biochemistry. Its unique structural features and reactivity make it a valuable tool for drug discovery and fundamental research. As advancements continue to be made in synthetic methodologies and biological understanding, this compound is poised to contribute significantly to future therapeutic developments.

• 1723-00-8((2R)-piperidine-2-carboxylic acid)
• 4043-87-2(DL-Pipecolinic acid)
• 103201-78-1((2S,4S)-4-cyclohexylpyrrolidine-2-carboxylic acid)
• 609-36-9(pyrrolidine-2-carboxylic acid)
• 51-35-4(L-Hydroxyproline)
• 2584-71-6((2R,4R)-4-hydroxypyrrolidine-2-carboxylic acid)
• 471-87-4(Stachydrine)
• 535-75-1(Pipecolic acid)
• 147-85-3(L-Proline)
• 344-25-2(D-Proline)